Scrivo R, Diamanti AP, Chimenti MS, Molteni E, Sciarra G, Bari F, et al. Secukinumab Treatment in Patients with Spondyloarthritis and Concomitant Demyelinating Disease: Rationale of IL-17 Inhibition and Clinical Outcome. acmcr [Internet]. 2022 Oct. 5 [cited 2026 Jun. 15];6(5):660-8. Available from: https://fortunejournals.org/ojs/index.php/acmcr/article/view/22670